We are a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with significant unmet medical needs in immunology and oncology. Our proprietary Tailored ...Covalency® platform enables us to design and develop reversible and irreversible covalent small molecule inhibitors with potencies and selectivities that we believe will rival those of injectable biologics, yet maintain the convenience of a pill. Our strategy is to advance the development of our proprietary drug candidates, and for certain programs, use collaborations and partnerships as strategic tools to maximize the value of those assets. Read more
Find prospects by the technologies they use. Use this section to learn more about the key technologies and tools used by Principia Biopharma and how they affect the user interaction and engagement with the company. Explore 68 technologies across 16 categories used by Principia Biopharma
Instantly reveal the technology stack of any website. Generate a free report by analyzing a list of your customers to find the top 5 common technologies currently being used across your customers.
Are you looking for the decision-makers at Principia Biopharma?
Get their email address, phone numbers, and other details from Linkedin or any website. Install and uncover Principia Biopharma’s employee details in less than 30 secs.
To find emails, direct dials, target and connect with more prospects on LinkedIn and anywhere on the web.
Discover Principia Biopharma alternatives or similar companies to benchmark and competitors' market analysis. Build a competitive intelligence sales and marketing strategy based on the data and stand out in the market.
10 - 19
50 - 99
South San Francisco
BioElectron Technology Corporation
50 - 99
Sales prospecting needs to be timely and appropriate for the person and organization you are contacting. Following the most recent company news, alerts, and updates about the leads you are currently working on is the simplest and most convenient way to stay on top of them. Here are Principia Biopharma latest news, alerts and updates.
(RTTNews) - Sanofi (SNYNF, SNY), on Friday, said it intends to commence a tender offer to acquire all of the outstanding shares of common stock of Principia Biopharma Inc. for $100 per share in cash,
Sanofi SA, a French multinational pharmaceutical company headquartered in Paris, said it would acquire a U.S.-based biopharmaceutical company Principia Biopharma for approximately $3.7 billion, sending its shares up about 1%.
Sanofi announced today that it agreed to acquire all outstanding shares of Principia Biopharma in a deal worth approximately $3.68 billion.
Sanofi and Principia Biopharma Inc. entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Principia for
Under the terms of the agreement, Sanofi will acquire all outstanding shares of Principia for $100 per share in cash, which represents an aggregate equity value of about $3.68 billion. The tender offer is expected to commence later this month,
Get ReportÂ reached an agreement to acquire Principia BiopharmaÂ (PRNB) - Get Report, the U.S. biotech company, in an all-cash deal with an equity value of about $3.68 billion. The French drugmaker will pay $100 a share for Principia Biopharma,
French pharma giant Sanofi has agreed to purchase Principa Biopharma in a deal that will be worth $3.7bn. Sanofi is eyeing up the expansion of its autoimmune disease drug line after announcing plans to acquire Principa Biopharma whose headquarters is based in San Francisco.
The Sanofi and Principia Boards of Directors unanimously approved the transaction. Topics: Sanofi Principia Biopharma Sanofi said the acquisition of Principia Biopharma, which dev
Sanofi and Principia Biopharma Inc. (NASDAQ: PRNB ), a late-stage biopharmaceutical company focused on developing treatments for immune-mediated diseases, entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Principia for $100 per share in cash,
Explore frequently asked questions about Principia Biopharma’s business, including founding details, header quarters, information on technology stack, industry listing, and other details.
Slintel keeps track of 100 - 249 employees who are working at Principia Biopharma. You can find more about their employees through LinkedIn or their website using Slintel Chrome Extension. Also, check out the jobs and hiring category at Principia Biopharma mentioned earlier on this page to identify which sector the company is growing.
Principia Biopharma is in the industry of Biotechnology.
Principia Biopharma headquarters are at South San Francisco, California, United States. To know the exact address unlock now.